Using purified botanical cannabidiol (CBD) to treat mouse models of Davet syndrome improved mortality and reduced behavioral symptoms associated with the condition. Read More
Mice expressing a specific variant of the Scn1a gene associated with Dravet syndrome exhibited spontaneous seizures, disordered breathing and died prematurely. Read More
Results from a phase 3 study reveal Cannabidiol (CBD) cuts seizures by almost 50% in children with Dravet syndrome. Read More
Researchers shed light on the endocannabinoid system and report how cannabis is helping to provide relief to many with medical problems. Read More
A new study reports a 39 to 46% reduction in seizures in children with Dravet syndrome and Lennox-Gastaut syndrome when given CBD based treatments. Read More
Researchers say a new cannabis derived drug, which is expected to receive full approval from the FDA this week, will be a vital intervention for children with Dravet Syndrome and Lennox-Gastaut syndrome. Read More
Researchers provide further evidence that the cannabis compound, CBD, is effective at reducing seizures in people with epilepsy. The new study reveals CBD significantly reduced seizures in people with Lennox-Gastaut syndrome. Previously, the researchers demonstrated CBD was effective at seizure control in Dravet syndrome. Read More
A new PNAS paper reports cannabidiol can help reduce epileptic seizures and improve social behaviors in children with Dravet syndrome. Read More
A cannabis derivative reduced seizure frequency by 39% in patients with Dravet syndrome. Read More
Researchers report a group of genes previously associated with rare forms of epilepsy may also contribute to common forms of the disorder. Read More
Researchers have identified a network of 320 genes they believe to be associated with epilepsy. Read More
Huperzine A, a compound that comes from a club moss, has been shown to increase resistance to induced seizures in mouse models of genetic epilepsy, a new study reports. Read More
